Edition:
United States

Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

21.10CHF
8 Dec 2017
Change (% chg)

CHF0.20 (+0.96%)
Prev Close
CHF20.90
Open
CHF21.15
Day's High
CHF21.35
Day's Low
CHF21.00
Volume
242,471
Avg. Vol
335,678
52-wk High
CHF22.90
52-wk Low
CHF10.00

Latest Key Developments (Source: Significant Developments)

Idorsia ‍Q3 US GAAP operating loss at CHF 68 mln
Tuesday, 24 Oct 2017 01:00am EDT 

Oct 24 (Reuters) - IDORSIA LTD :‍US GAAP OPERATING LOSS IN Q3 2017: CHF 68 MILLION / YTD* 2017: CHF 79 MILLION​.‍NON-GAAP** OPERATING LOSS IN Q3 2017: CHF 61 MILLION / YTD* 2017: CHF 71 MILLION​.‍GUIDANCE FOR FULL YEAR 2017: NON-GAAP OPERATING EXPENSES OF CHF 160-170 MILLION​.‍AT END OF Q3, IDORSIA'S LIQUIDITY AMOUNTED TO CHF 952 MILLION​.‍9MTH US GAAP NET LOSS AMOUNTED TO CHF 82 MILLION RESULTING IN A NET LOSS PER SHARE OF CHF 0.73​.  Full Article

Idorsia to get $230 million from J&J in latest hypertension deal

ZURICH Idorsia , the Swiss drugmaker spun off from Actelion after it was bought by Johnson & Johnson (J&J) , will receive a one-time payment of $230 million from J&J's Janssen unit as they partner on aprocitentan for resistant hypertension.